Anika Therapeutics, Inc.ANIKNASDAQ
Loading
Operating Cash Flow Growth Under PressureDecelerating
Percentile Rank86
Studio
Year-over-Year Change

Year-over-year operating cash flow growth rate

Latest
107.07%
↑ 338% vs avg
Percentile
P86
Within normal range
Streak
1 yr
Consecutive declineDecelerating
Average
24.47%
Historical baseline
PeriodValue
2025107.07%
2024402.18%
2023-140.55%
2022-47.49%
2021-35.73%
2020-64.69%
20195.98%
2018-14.44%
201771.47%
2016-39.07%